Noven is a fully-integrated specialty pharmaceutical company with industry-leading transdermal expertise

About Noven - Governance


Noven Pharmaceuticals, Inc. and its Noven Therapeutics subsidiary are mutually committed to maintaining the highest standards of professionalism, ethics, integrity, and compliance across their respective businesses, activities, and interactions.

Each document appearing below is saved as a printable Adobe Acrobat Reader PDF file. You must have Adobe Acrobat Reader installed on your computer to read these files. Click on blue headers to access each document via PDF. If you do not have Reader, you can download a free version here.

    Code of Business Conduct and Ethics

    Noven has adopted a Code of Business Conduct and Ethics that applies to our directors, officers and employees.

    Compliance Program

    As part of our commitment to deliver meaningful benefits to patients using our products and to conduct business honestly, lawfully, and ethically, Noven has established a Comprehensive Compliance Program:

    The Physician Payment Sunshine Act
    The federal Physician Payment Sunshine Act of 2010 requires pharmaceutical, biologic, and medical device manufacturers to annually disclose to the Centers for Medicare & Medicaid Services (CMS) in the Department of Health and Human Services (DHHS) payments and other transfers of value furnished to physicians and teaching hospitals. Click here to learn more about the Sunshine Act, what it means for physicians and Noven's Commitment.

    For questions specific to Noven's approach to the Sunshine Act, please send an email to

    California Supply Chains Act Disclosure
    The 2010 California Transparency in Supply Chains Act requires companies to disclose their efforts to eradicate slavery and human trafficking from their supply chain. Noven opposes slavery and human trafficking and is committed to conducting its business in a lawful and ethical manner and requires its suppliers to conduct themselves in the same manner.

Fast Facts

Core Business:

Specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products.

Year of Incorporation:



Over 325

Chairman &
Chief Executive Officer:

Dr. Naruhito Higo

Media, General Business
& Other Inquiries:

Tel: 305-253-1916

Partnering and Other Business Development Opportunities

Tel: 551-233-2700

Physican Payment
Sunshine Act Inquiries:

Employment Inquiries:

Rory Kelly
Associate Director – Recruiting
Careers Page

Community Support:

Corporate Social Responsibility

Affiliated Companies:

Noven is a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc. – bringing the benefits of patch therapy to patients around the world.

Noven's commercialized products are marketed and sold through Noven Therapeutics, LLC.

Grove Pharmaceuticals is the generic division of Noven Therapeutics, LLC.